---
schema_version: "secwatch.filing_event.v1"
accession: "0001847903-24-000095"
form_type: "8-K"
ticker: "CNTA"
cik: "0001847903"
company_name: "Centessa Pharmaceuticals plc"
filed_at: "2024-06-25T23:59:59+00:00"
generated_at: "2026-06-01T02:18:22.605458+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Centessa shareholders approve all proposals at 2024 AGM

## Summary
- Directors Francesco De Rubertis, Saurabh Saha, and Mary Lynne Hedley re-elected with 67.8M, 76.4M, and 76.6M votes For respectively.
- KPMG LLP (UK) re-appointed as statutory auditor, and KPMG LLP (US) ratified as independent auditor, each with 88.9M For votes.
- Advisory resolution to approve directors' remuneration report passed with 76.7M For votes.
- Authority to allot shares up to £100,740 nominal and disapply pre-emption rights approved with 68.0M and 64.6M For votes respectively.
- All resolutions passed; no dividend recommended for FY2023.

## SEC filing metadata
- accession: 0001847903-24-000095
- form_type: 8-K
- ticker: CNTA
- cik: 0001847903
- company_name: Centessa Pharmaceuticals plc
- filed_at: 2024-06-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847903/000184790324000095/0001847903-24-000095-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847903/000184790324000095/cnta-20240625.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001847903-24-000095
- JSON: https://secwatch.observer/filing/0001847903-24-000095.json
- Plain text: https://secwatch.observer/filing/0001847903-24-000095.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.